COMP <GO>
APT vs MRK // FREE CASH FLOW YIELD
Alpha Pro Tech Ltd. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: APT 4
— MRK 8
▲ FREE CASH FLOW YIELD LEADER: MRK
LAST: $5.40 (-2.70%) • MKT CAP: $56.6M
fcf-yield
3.06%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APT VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APT | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.10% | 74.80% | -36.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.70% | 20.70% | -14.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.0x | 15.3x | -6.30 | APT | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 3.06% | 3.42% | -0.36 | MRK | /fcf-yield <GO> |
| Operating Margin | 6.50% | 34.30% | -27.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 5.90% | 28.10% | -22.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | — | 1.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.59 | 5.19 | +0.40 | APT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.2 | 51.7 | +0.50 | APT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.1x | 18.4x | -3.30 | APT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $56.6M | $361.02B | -$360.96B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APT REV | MRK REV | APT GROSS % | MRK GROSS % | APT FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $59.1M | $65.01B | 38.1% | 74.8% | $1.7M | $12.36B |
| FY 2024 | $57.8M | $64.17B | 39.6% | 76.3% | $1.9M | $18.10B |
| FY 2023 | $0 | $60.12B | — | — | $8.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APT // BETA —
MRK // BETA 0.92